Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1

Tomoaki Ishida; Shu Nakao; Tomoe Ueyama; Yukihiro Harada; Teruhisa Kawamura

doi:10.1186/s41232-020-00117-8

Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1

Inflamm Regen. 2020 May 12:40:8. doi: 10.1186/s41232-020-00117-8. eCollection 2020.

Authors

Tomoaki Ishida^{1

2}, Shu Nakao^{1

2}, Tomoe Ueyama^{1

2}, Yukihiro Harada^{1

2}, Teruhisa Kawamura^{1

2}

Affiliations

¹ 1Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
² 2Ritsumeikan Global Innovation Research Organization, Ritsumeikan University, Kusatsu, Japan.

Abstract

Induced pluripotent stem cells (iPSCs) were first established from differentiated somatic cells by gene introduction of key transcription factors, OCT4, SOX2, KLF4, and c-MYC, over a decade ago. Although iPSCs can be applicable for regenerative medicine, disease modeling and drug screening, several issues associated with the utilization of iPSCs such as low reprogramming efficiency and the risk of tumorigenesis, still need to be resolved. In addition, the molecular mechanisms involved in the somatic cell reprogramming to pluripotency are yet to be elucidated. Compared with their somatic counterparts, pluripotent stem cells, including embryonic stem cells and iPSCs, exhibit a high rate of glycolysis akin to aerobic glycolysis in cancer cells. This is known as the Warburg effect and is essential for maintaining stem cell properties. This unique glycolytic metabolism in iPSCs can provide energy and drive the pentose phosphate pathway, which is the preferred pathway for rapid cell proliferation. During reprogramming, somatic cells undergo a metabolic shift from oxidative phosphorylation (OXPHOS) to glycolysis trigged by a transient OXPHOS burst, resulting in the initiation and progression of reprogramming to iPSCs. Metabolic intermediates and mitochondrial functions are also involved in the epigenetic modification necessary for the process of iPSC reprogramming. Among the key regulatory molecules that have been reported to be involved in metabolic shift so far, hypoxia-inducible factor 1 (HIF1) controls the transcription of many target genes to initiate metabolic changes in the early stage and maintains glycolytic metabolism in the later phase of reprogramming. This review summarizes the current understanding of the unique metabolism of pluripotent stem cells and the metabolic shift during reprogramming, and details the relevance of HIF1 in the metabolic shift.

Keywords: Glycolysis; Hypoxia-inducible factor; Induced pluripotent stem cells; Metabolic shift; Oxidative phosphorylation; Regenerative medicine; Reprogramming.

Publication types

Review